Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
3SBio Inc.
3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
May 23rd, 2009
3SBio Inc. (NASDAQ:SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced the appointment of Ernst & Young Hua Ming ("Ernst & Young") as the Company's independent registered public accounting firm. Ernst & Young replaces KPMG, previously the independent auditor for 3SBio. Ernst & Young has begun providing services effective immediately and is working with 3SBio and KPMG to ensure a seamless transition. The dismissal of KPMG and the appointment of Ernst & Young have been approved by the Audit Committee, with the concurrence of the Board of...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2009-05-23)
|
